The gastrointestinal, genitourinary, and neurovascular systems are frequent
targets of the autonomic complications of diabetes. Complications affectin
g these systems contribute greatly to the morbidity, mortality; and reduced
quality of life and activities of daily living of the person with diabetes
. They are also the major source of increased costs of caring for the diabe
tic patient, impairments range from functional disturbances related to hype
r- or hypoglycemia and age, duration of diabetes, and quality of diabetes c
ontrol and evolve into organic disorders with loss of parasympathetic, symp
athetic, and neuropeptidergic nerves, Factors in the pathogenesis are metab
olism, vascular insufficiency, loss of growth factor trophism, and autoimmu
ne destruction of small unmyelinated nerves (C fibers) in a visceral and cu
taneous distribution. The clinical manifestations range from anorexia, naus
ea, vomiting, brittle diabetes, diarrhea, constipation, loss of bladder con
trol, and erectile dysfunction to impaired skin blood flow responses to hea
ting and cooling, nociception, and gravity, with loss of amplitudes of vasc
ular oscillation and premature aging of the neurovascular system. The disor
dered skin blood flow is a major factor in the development of foot ulcers a
nd amputations. Treatments are limited to symptoms; algorithms for the many
facets of these disorders are provided here? including one for gastrointes
tinal abnormalities and another for erectile dysfunction. Ultimately, treat
ment directed at the underlying pathogenic mechanisms of these manifestatio
ns is sorely needed.